Literature DB >> 22548958

NPSR1 gene is associated with reduced risk of rheumatoid arthritis.

Gema Robledo1, Miguel Angel González-Gay, Benjamín Fernández-Gutiérrez, José Ramón Lamas, Alejandro Balsa, Dora Pascual-Salcedo, Santos Castañeda, Ricardo Blanco, Isidoro González-Alvaro, Antonio García, Enrique Raya, Carmen Gómez-Vaquero, Mario Delgado, Javier Martín.   

Abstract

OBJECTIVE: Neuropeptide S receptor 1 (NPSR1) is a G protein-coupled receptor involved in immune response and is associated with several inflammatory diseases. We investigated the possible contribution of several polymorphisms in the intronic region of NPSR1 to rheumatoid arthritis (RA).
METHODS: Genotyping of 7 single-nucleotide polymorphisms (SNP) was performed in a total of 1232 patients with RA and 983 healthy controls of Spanish white origin by real-time polymerase chain reaction technology, using the TaqMan 5'-allele discrimination assay.
RESULTS: One out of the 7 SNP analyzed (rs740347) was associated with RA [p after Bonferroni correction (p(BNF)) = 1.2 × 10(-3), OR 0.73]. An association was also observed with rheumatoid factor-positive and shared epitope-positive RA (p(BNF) = 0.011, OR 0.73; p(BNF) = 0.037, OR 0.75, respectively).
CONCLUSION: Our results show that variations in the NPSR1 intronic region are associated with low risk in patients with RA, supporting other evidence that this locus represents a common genetic factor in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548958     DOI: 10.3899/jrheum.111205

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

2.  Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma.

Authors:  Nathalie Acevedo; Sini Ezer; Simon Kebede Merid; Vincent D Gaertner; Cilla Söderhäll; Mauro D'Amato; Michael Kabesch; Erik Melén; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

3.  Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma.

Authors:  Nathalie Acevedo; Annika Sääf; Cilla Söderhäll; Erik Melén; Jami Mandelin; Christina Orsmark Pietras; Sini Ezer; Piia Karisola; Johanna Vendelin; Gustav Boije af Gennäs; Jari Yli-Kauhaluoma; Harri Alenius; Erika von Mutius; Gert Doekes; Charlotte Braun-Fahrländer; Josef Riedler; Marianne van Hage; Mauro D'Amato; Annika Scheynius; Göran Pershagen; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

4.  Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors.

Authors:  V Pulkkinen; S Ezer; L Sundman; J Hagström; S Remes; C Söderhäll; D Greco; G Dario; C Haglund; J Kere; J Arola
Journal:  Virchows Arch       Date:  2014-06-12       Impact factor: 4.064

5.  Gene polymorphisms (rs324957, rs324981) in NPSR1 are associated with increased risk of primary insomnia: A cross-sectional study.

Authors:  Yuping Xie; Yuan Zhao; Liya Zhou; Lijun Zhao; Jinfeng Wang; Wei Ma; Xiaoyan Su; Peilin Hui; Bin Guo; Yu Liu; Jie Fan; Shangli Zhang; Jun Yang; Wenjuan Chen; Jing Wang
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.